marketcaparena
Search

    ENTA

    ENANTA PHARMACEUTICALS INC

    Company overview

    Market capitalization
    $366.82M
    Employees
    120
    Latest publication
    2026-09-29
    About ENANTA PHARMACEUTICALS INC

    Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for virology and immunology indications. The company's product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; zelicapavir and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; EDP-978 for chronic spontaneous urticaria (CSU); Glecaprevir, antiviral protease inhibitors for the treatment of chronic infection with hepatitis C virus or HCV; and EPS-3903 for the treatment of atopic dermatitis. It has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. The company was incorporated in 1995 and is headquartered in Watertown, Massachusetts.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ3 20262026-06-30 · USDQ2 20262026-03-31 · USDQ1 20262025-12-31 · USDQ4 20252025-09-30 · USDQ3 20252025-06-30 · USDQ2 20252025-03-31 · USDQ1 20252024-12-31 · USDQ4 20242024-09-30 · USD
    Total Revenue14,359,000USD17,159,000USD18,615,000USD15,125,000USD18,314,000USD14,926,000USD16,959,000USD14,607,000USD
    Cost Of Revenue0USD0USD0USD—0USD0USD0USD—
    Gross Profit14,359,000USD17,159,000USD18,615,000USD—18,314,000USD14,926,000USD16,959,000USD—
    Research Development22,126,000USD19,443,000USD20,859,000USD23,809,000USD27,210,000USD28,065,000USD27,656,000USD30,778,000USD
    Selling General Administrative9,469,000USD9,568,000USD9,009,000USD—9,997,000USD11,388,000USD12,846,000USD—
    General And Administrative Expenses9,469,000USD9,568,000USD9,009,000USD—9,997,000USD11,388,000USD12,846,000USD—
    Total Operating Expenses31,595,000USD29,011,000USD29,868,000USD33,511,000USD37,207,000USD39,453,000USD40,502,000USD44,461,000USD
    Operating Income-17,236,000USD-11,852,000USD-11,253,000USD—-18,893,000USD-24,527,000USD-23,543,000USD—
    Total Other Income Expense Net-2,229,000USD-1,232,000USD-661,000USD—667,000USD578,000USD837,000USD—
    Interest Expense4,130,000USD3,316,000USD3,083,000USD—1,618,000USD1,714,000USD1,962,000USD—
    Income Before Tax-19,465,000USD-13,084,000USD-11,914,000USD—-18,226,000USD-23,949,000USD-22,706,000USD—
    Income Tax Expense36,000USD7,000USD24,000USD—29,000USD-1,305,000USD-416,000USD—
    Net Income-19,501,000USD-13,091,000USD-11,938,000USD-18,700,000USD-18,255,000USD-22,644,000USD-22,290,000USD-28,823,000USD
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosurePreliminaryDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosurePreliminary

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-09-30 · USDFY 20242024-09-30 · USDFY 20232023-09-30 · USDFY 20222022-09-30 · USDFY 20212021-09-30 · USDFY 20202020-09-30 · USDFY 20192019-09-30 · USDFY 20182018-09-30 · USD
    Total Revenue65,324,000USD67,635,000USD79,204,000USD86,160,000USD97,074,000USD122,473,000USD205,197,000USD206,625,000USD
    Cost Of Revenue0USD0USD0USD0USD0USD0USD0USD0USD
    Gross Profit65,324,000USD67,635,000USD79,204,000USD86,160,000USD97,074,000USD122,473,000USD205,197,000USD206,625,000USD
    Research Development106,740,000USD131,476,000USD163,524,000USD164,522,000USD174,111,000USD136,756,000USD142,213,000USD94,856,000USD
    Selling General Administrative43,933,000USD57,850,000USD52,887,000USD45,482,000USD32,536,000USD27,356,000USD26,246,000USD23,441,000USD
    General And Administrative Expenses43,933,000USD57,850,000USD52,887,000USD45,482,000USD32,536,000USD27,356,000USD26,246,000USD23,441,000USD
    Total Operating Expenses150,673,000USD189,326,000USD216,411,000USD210,004,000USD206,647,000USD164,112,000USD168,459,000USD118,297,000USD
    Operating Income-85,349,000USD-121,691,000USD-137,207,000USD-123,844,000USD-109,573,000USD-41,639,000USD36,738,000USD88,328,000USD
    Total Other Income Expense Net1,800,000USD3,903,000USD6,212,000USD1,656,000USD1,994,000USD6,620,000USD8,819,000USD4,793,000USD
    Interest Expense7,681,000USD10,940,000USD5,148,000USD—————
    Income Before Tax-83,549,000USD-117,788,000USD-130,995,000USD-122,188,000USD-107,579,000USD-35,019,000USD45,557,000USD93,121,000USD
    Income Tax Expense-1,660,000USD-1,743,000USD2,821,000USD-433,000USD-28,583,000USD1,149,000USD-826,000USD21,165,000USD
    Net Income-81,889,000USD-116,045,000USD-133,816,000USD-121,755,000USD-78,996,000USD-36,168,000USD46,383,000USD71,956,000USD
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinal

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ3 20262026-06-30 · USDQ2 20262026-03-31 · USDQ1 20262025-12-31 · USDQ4 20252025-09-30 · USDQ3 20252025-06-30 · USDQ2 20252025-03-31 · USDQ1 20252024-12-31 · USDQ4 20242024-09-30 · USD
    Total Assets296,870,000USD314,704,000USD329,503,000USD280,732,000USD301,029,000USD322,993,000USD348,642,000USD376,652,000USD
    Cash And Equivalents33,419,000USD34,928,000USD37,437,000USD32,298,000USD44,812,000USD60,213,000USD84,349,000USD37,233,000USD
    Long Term Investments21,987,000USD63,238,000USD56,055,000USD—————
    Total Current Assets203,619,000USD178,412,000USD198,684,000USD204,336,000USD222,708,000USD242,860,000USD268,145,000USD299,852,000USD
    Other Current Assets7,579,000USD6,810,000USD4,342,000USD8,590,000USD10,240,000USD8,857,000USD10,684,000USD12,413,000USD
    Other Non Current Assets110,000USD144,000USD93,000USD92,000USD94,000USD98,000USD94,000USD94,000USD
    Total Liabilities195,802,000USD198,117,000USD202,912,000USD216,015,000USD221,750,000USD229,455,000USD236,826,000USD247,838,000USD
    Total Current Liabilities54,166,000USD46,442,000USD44,728,000USD48,555,000USD44,549,000USD45,947,000USD49,050,000USD57,535,000USD
    Other Current Liabilities10,183,000USD6,859,000USD7,575,000USD12,751,000USD10,853,000USD8,314,000USD10,575,000USD13,547,000USD
    Other Non Current Liabilities286,000USD278,000USD269,000USD260,000USD252,000USD243,000USD235,000USD231,000USD
    Total Stockholder Equity101,068,000USD116,587,000USD126,591,000USD64,717,000USD79,279,000USD93,538,000USD111,816,000USD128,814,000USD
    Total Equity Including Noncontrolling Interest101,068,000USD116,587,000USD126,591,000USD64,717,000USD79,279,000USD93,538,000USD111,816,000USD128,814,000USD
    Net Receivables6,534,000USD7,809,000USD8,493,000USD6,882,000USD8,333,000USD6,792,000USD7,718,000USD6,646,000USD
    Property Plant Equipment Net67,794,000USD69,550,000USD71,311,000USD72,944,000USD74,867,000USD76,675,000USD77,043,000USD73,346,000USD
    Accounts Payable3,293,000USD4,363,000USD1,885,000USD1,948,000USD3,547,000USD4,756,000USD4,726,000USD8,002,000USD
    Short Term Debt3,906,000USD3,759,000USD3,287,000USD3,146,000USD2,394,000USD2,196,000USD1,006,000USD1,524,000USD
    Common Stock291,000USD291,000USD290,000USD214,000USD214,000USD214,000USD213,000USD212,000USD
    Retained Earnings-449,459,000USD-429,958,000USD-416,867,000USD-404,929,000USD-386,229,000USD-367,974,000USD-345,330,000USD-323,040,000USD
    Accumulated Other Comprehensive Income-927,000USD-734,000USD-329,000USD-339,000USD-402,000USD-224,000USD-29,000USD302,000USD
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinal

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-09-30 · USDFY 20242024-09-30 · USDFY 20232023-09-30 · USDFY 20222022-09-30 · USDFY 20212021-09-30 · USDFY 20202020-09-30 · USDFY 20192019-09-30 · USDFY 20182018-09-30 · USD
    Total Assets280,732,000USD376,652,000USD462,275,000USD375,410,000USD438,791,000USD486,132,000USD489,829,000USD414,227,000USD
    Cash And Equivalents32,298,000USD37,233,000USD85,388,000USD43,994,000USD57,206,000USD87,131,000USD51,230,000USD63,902,000USD
    Total Current Assets204,336,000USD299,852,000USD422,791,000USD311,713,000USD319,021,000USD436,837,000USD401,848,000USD380,389,000USD
    Other Current Assets8,590,000USD12,413,000USD13,263,000USD13,445,000USD14,188,000USD26,696,000USD15,299,000USD4,454,000USD
    Other Non Current Assets92,000USD94,000USD803,000USD696,000USD92,000USD92,000USD92,000USD92,000USD
    Total Liabilities216,015,000USD247,838,000USD245,540,000USD54,076,000USD39,362,000USD30,552,000USD27,337,000USD20,548,000USD
    Total Current Liabilities48,555,000USD57,535,000USD62,787,000USD29,827,000USD36,172,000USD24,157,000USD22,609,000USD16,025,000USD
    Other Current Liabilities12,751,000USD13,547,000USD18,339,000USD20,936,000USD22,429,000USD14,159,000USD15,920,000USD9,892,000USD
    Other Non Current Liabilities260,000USD231,000USD663,000USD454,000USD558,000USD1,078,000USD3,100,000USD2,895,000USD
    Total Stockholder Equity64,717,000USD128,814,000USD216,735,000USD321,334,000USD399,429,000USD455,580,000USD462,492,000USD393,679,000USD
    Total Equity Including Noncontrolling Interest64,717,000USD128,814,000USD216,735,000USD321,334,000USD399,429,000USD455,580,000USD462,492,000USD393,679,000USD
    Net Receivables6,882,000USD6,646,000USD8,614,000USD20,318,000USD23,576,000USD23,492,000USD51,313,000USD67,205,000USD
    Property Plant Equipment Net72,944,000USD73,346,000USD34,713,000USD29,748,000USD10,654,000USD15,616,000USD10,927,000USD8,374,000USD
    Accounts Payable1,948,000USD8,002,000USD4,097,000USD6,000,000USD9,540,000USD5,737,000USD6,689,000USD4,745,000USD
    Short Term Debt3,146,000USD1,524,000USD5,275,000USD2,891,000USD4,203,000USD4,261,000USD——
    Common Stock214,000USD212,000USD211,000USD208,000USD202,000USD201,000USD197,000USD194,000USD
    Retained Earnings-404,929,000USD-323,040,000USD-206,995,000USD-73,179,000USD48,576,000USD127,572,000USD163,740,000USD117,357,000USD
    Accumulated Other Comprehensive Income-339,000USD302,000USD-1,174,000USD-3,724,000USD-382,000USD844,000USD146,000USD-398,000USD
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinal

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-03-31 · USDQ3 20252025-06-30 · USDQ2 20252025-03-31 · USDQ3 20242024-06-30 · USDQ2 20242024-03-31 · USDQ3 20232023-06-30 · USDQ2 20232023-03-31 · USDQ3 20222022-06-30 · USD
    Depreciation2,439,000USD3,302,000USD2,092,000USD1,857,000USD1,263,000USD1,702,000USD1,051,000USD2,318,000USD
    Stock Based Compensation7,558,000USD14,531,000USD10,354,000USD19,077,000USD13,660,000USD21,500,000USD14,502,000USD20,136,000USD
    Change To Account Receivables-927,000USD-1,687,000USD-146,000USD438,000USD858,000USD1,426,000USD2,523,000USD4,097,000USD
    Change To Liabilities-3,459,000USD-2,927,000USD-4,166,000USD-5,359,000USD-7,887,000USD-696,000USD-135,000USD-11,925,000USD
    Change In Working Capital3,216,000USD-102,000USD4,111,000USD263,000USD4,066,000USD348,000USD7,447,000USD-2,421,000USD
    Operating Cash Flow-18,855,000USD-12,783,000USD-30,289,000USD-68,364,000USD-53,589,000USD-81,552,000USD-49,424,000USD-69,248,000USD
    Capital Expenditures-158,000USD-11,438,000USD-11,283,000USD-8,997,000USD-2,455,000USD-7,690,000USD-5,539,000USD-688,000USD
    Net Investments-35,198,000USD49,489,000USD75,817,000USD48,159,000USD47,962,000USD-57,724,000USD85,873,000USD27,354,000USD
    Investing Cash Flow-35,356,000USD38,051,000USD64,534,000USD39,162,000USD45,507,000USD-65,414,000USD80,334,000USD26,666,000USD
    Net Common Stock Issuance-402,000USD-267,000USD-264,000USD-275,000USD-275,000USD-3,734,000USD-3,734,000USD-1,228,000USD
    Unclassified Financing Cash Flow57,243,000USD-18,030,000USD-11,609,000USD-20,136,000USD-13,489,000USD201,883,000USD2,008,000USD18,331,000USD
    Financing Cash Flow56,841,000USD-18,297,000USD-11,873,000USD-20,411,000USD-13,764,000USD198,149,000USD-1,726,000USD17,103,000USD
    Change In Cash2,630,000USD6,971,000USD22,372,000USD-49,613,000USD-21,846,000USD51,183,000USD29,184,000USD-25,479,000USD
    End Cash Flow38,288,000USD48,172,000USD63,573,000USD39,743,000USD67,510,000USD99,145,000USD77,146,000USD32,335,000USD
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-03-31 · USDQ1 20262025-12-31 · USDQ4 20252025-09-30 · USDQ3 20252025-06-30 · USDQ2 20252025-03-31 · USDQ1 20252024-12-31 · USDQ4 20242024-09-30 · USDQ3 20242024-06-30 · USD
    Net Income-13,091,000USD—-18,700,000USD-18,255,000USD-22,644,000USD—-28,823,000USD-22,658,000USD
    Depreciation1,209,000USD1,230,000USD1,284,000USD1,210,000USD1,203,000USD889,000USD479,000USD594,000USD
    Stock Based Compensation3,748,000USD3,810,000USD4,034,000USD4,177,000USD4,688,000USD5,666,000USD7,718,000USD5,417,000USD
    Other Non Cash Items4,775,000USD—1,509,000USD-1,928,000USD1,155,000USD—1,062,000USD-823,000USD
    Change To Account Receivables665,000USD-1,611,000USD1,475,000USD32,271,000USD-466,000USD-1,072,000USD1,986,000USD-844,000USD
    Change In Working Capital-49,000USD2,573,000USD5,384,000USD32,302,000USD2,110,000USD489,000USD9,164,000USD2,695,000USD
    Total Cash From Operating Activities-7,156,000USD—-6,489,000USD17,506,000USD-13,488,000USD—-10,400,000USD-14,775,000USD
    Capital Expenditures-15,000USD-143,000USD-1,458,000USD-155,000USD-2,538,000USD-8,745,000USD-8,951,000USD-6,542,000USD
    Free Cash Flow-7,171,000USD—-7,947,000USD17,351,000USD-16,026,000USD—-19,351,000USD-21,317,000USD
    Investments11,957,000USD—3,754,000USD-26,483,000USD-4,369,000USD—19,073,000USD-6,345,000USD
    Total Cashflows From Investing Activities11,942,000USD—2,296,000USD-26,483,000USD-4,369,000USD—19,073,000USD-6,345,000USD
    Total Cash From Financing Activities-7,295,000USD—-8,321,000USD-6,424,000USD-6,887,000USD—-7,215,000USD-6,647,000USD
    Issuance Of Capital Stock0USD———0USD———
    Change In Cash-2,509,000USD5,139,000USD-12,514,000USD-15,401,000USD-24,744,000USD47,116,000USD1,458,000USD-27,767,000USD
    Begin Period Cash Flow37,437,000USD—48,172,000USD63,573,000USD88,317,000USD—39,743,000USD67,510,000USD
    End Period Cash Flow34,928,000USD—35,658,000USD48,172,000USD63,573,000USD—41,201,000USD39,743,000USD
    Other Cashflows From Financing Activities-7,344,000USD—18,114,000USD-6,330,000USD-6,887,000USD—-19,000USD-6,675,000USD
    Unclassified Operating Cash Flow-3,748,000USD———————
    Change To Liabilities—-5,230,000USD———-3,074,000USD——
    Operating Cash Flow—-11,699,000USD———-16,801,000USD——
    Net Investments—-47,155,000USD———77,648,000USD——
    Investing Cash Flow—-47,298,000USD———68,903,000USD——
    Net Common Stock Issuance—-97,000USD———-137,000USD——
    Unclassified Financing Cash Flow—64,233,000USD-26,435,000USD——-4,849,000USD——
    Financing Cash Flow—64,136,000USD———-4,986,000USD——
    End Cash Flow—40,797,000USD———88,317,000USD——
    Unclassified Investing Cash Flow————2,538,000USD—8,951,000USD6,542,000USD
    Net Borrowings——————-7,264,000USD—
    SourceLegacy providerLegacyDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-09-30 · USDFY 20242024-09-30 · USDFY 20232023-09-30 · USDFY 20222022-09-30 · USDFY 20212021-09-30 · USDFY 20202020-09-30 · USDFY 20192019-09-30 · USDFY 20182018-09-30 · USD
    Depreciation4,586,000USD2,336,000USD2,371,000USD2,973,000USD3,334,000USD3,644,000USD3,258,000USD2,518,000USD
    Stock Based Compensation18,565,000USD26,795,000USD28,216,000USD26,969,000USD20,991,000USD19,575,000USD19,226,000USD15,845,000USD
    Change To Account Receivables-236,000USD1,968,000USD11,704,000USD3,258,000USD-84,000USD27,821,000USD15,892,000USD-56,591,000USD
    Change To Liabilities-1,224,000USD-6,492,000USD-3,500,000USD-6,215,000USD11,604,000USD-3,173,000USD7,832,000USD3,724,000USD
    Change In Working Capital2,278,000USD3,113,000USD10,628,000USD-1,237,000USD3,157,000USD15,541,000USD5,450,000USD-64,194,000USD
    Operating Cash Flow-19,272,000USD-78,764,000USD-103,154,000USD-84,782,000USD-69,996,000USD7,088,000USD71,418,000USD29,220,000USD
    Capital Expenditures-12,896,000USD-17,948,000USD-9,058,000USD-2,125,000USD-750,000USD-1,445,000USD-5,417,000USD-2,981,000USD
    Net Investments53,243,000USD76,183,000USD-44,520,000USD57,022,000USD37,741,000USD21,275,000USD-81,247,000USD-32,421,000USD
    Investing Cash Flow40,347,000USD58,235,000USD-53,578,000USD54,897,000USD36,991,000USD19,830,000USD-86,664,000USD-35,402,000USD
    Net Common Stock Issuance-277,000USD-294,000USD-3,757,000USD-1,229,000USD-534,000USD-1,498,000USD-4,188,000USD-1,756,000USD
    Unclassified Financing Cash Flow-26,341,000USD-27,332,000USD201,883,000USD21,262,000USD3,614,000USD10,481,000USD6,762,000USD6,165,000USD
    Financing Cash Flow-26,618,000USD-27,626,000USD198,126,000USD20,033,000USD3,080,000USD8,983,000USD2,574,000USD4,409,000USD
    Change In Cash-5,543,000USD-48,155,000USD41,394,000USD-9,852,000USD-29,925,000USD35,901,000USD-12,672,000USD—
    End Cash Flow35,658,000USD41,201,000USD89,356,000USD47,962,000USD57,814,000USD87,739,000USD51,838,000USD—
    Deferred Income Tax——0USD0USD345,000USD-18,259,000USD-3,138,000USD1,858,000USD
    Other Non Cash Items——0USD0USD97,000USD51,000USD-25,000USD75,000USD
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinal

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    FY 2025Yearly · 2025-09-30ProductLicense0USDDisclosure
    FY 2025Yearly · 2025-09-30ProductRoyalty65,324,000USDDisclosure
    FY 2024Yearly · 2024-09-30ProductLicense0USDDisclosure
    FY 2024Yearly · 2024-09-30ProductRoyalty67,635,000USDDisclosure
    Q4 2024Quarterly · 2024-09-30ProductLicense0USDDisclosure
    Q4 2024Quarterly · 2024-09-30ProductRoyalty14,607,000USDDisclosure
    Q3 2024Quarterly · 2024-06-30ProductLicense0USDDisclosure
    Q3 2024Quarterly · 2024-06-30ProductRoyalty17,971,000USDDisclosure
    Q2 2024Quarterly · 2024-03-31ProductLicense0USDDisclosure
    Q2 2024Quarterly · 2024-03-31ProductRoyalty17,054,000USDDisclosure
    Q1 2024Quarterly · 2023-12-31ProductLicense0USDDisclosure
    Q1 2024Quarterly · 2023-12-31ProductRoyalty18,003,000USDDisclosure
    FY 2023Yearly · 2023-09-30ProductLicense1,000,000USDDisclosure
    FY 2023Yearly · 2023-09-30ProductRoyalty78,204,000USDDisclosure
    Q4 2023Quarterly · 2023-09-30ProductLicense0USDDisclosure
    Q4 2023Quarterly · 2023-09-30ProductRoyalty18,932,000USDDisclosure
    Q3 2023Quarterly · 2023-06-30ProductLicense0USDDisclosure
    Q3 2023Quarterly · 2023-06-30ProductRoyalty18,892,000USDDisclosure
    Q2 2023Quarterly · 2023-03-31ProductLicense0USDDisclosure
    Q2 2023Quarterly · 2023-03-31ProductRoyalty17,795,000USDDisclosure
    Q1 2023Quarterly · 2022-12-31ProductLicense1,000,000USDDisclosure
    Q1 2023Quarterly · 2022-12-31ProductRoyalty22,585,000USDDisclosure
    FY 2022Yearly · 2022-09-30ProductLicense0USDDisclosure
    FY 2022Yearly · 2022-09-30ProductRoyalty86,160,000USDDisclosure
    FY 2021Yearly · 2021-09-30ProductLicense0USDDisclosure
    FY 2021Yearly · 2021-09-30ProductRoyalty97,074,000USDDisclosure
    FY 2018Yearly · 2018-09-30ProductMilestone15,000,000USDDisclosure
    FY 2018Yearly · 2018-09-30ProductRoyalty191,625,000USDDisclosure
    FY 2017Yearly · 2017-09-30ProductMilestone65,000,000USDDisclosure
    FY 2017Yearly · 2017-09-30ProductRoyalty37,814,000USDDisclosure
    FY 2016Yearly · 2016-09-30ProductGrant576,000USDDisclosure
    FY 2016Yearly · 2016-09-30ProductMilestone30,000,000USDDisclosure
    FY 2016Yearly · 2016-09-30ProductRoyalty57,692,000USDDisclosure

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.